Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Doravirine in the Rapid Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-1positive Patients Without Prior Treatment

NCT07357584 is registered in ClinicalTrials.gov with Fundación Huésped as lead sponsor.

NCT NCT07357584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Doravirine in the Rapid Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-1positive Patients Without Prior Treatment
Lead sponsor
Fundación Huésped
Phase
Phase 4
Overall status
Recruiting
Start date
September 16, 2026
Completion date
April 30, 2028
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection